Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy?: Implications for pathology testing

Emmanuel J Favaloro; Leonardo Pasalic; Giuseppe Lippi

doi:10.1016/j.pathol.2017.04.011

Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy? Implications for pathology testing

Emmanuel J Favaloro, Leonardo Pasalic, Giuseppe Lippi

Dentistry and Medical Sciences

Research output: Contribution to journal › Letter › peer-review

31 Citations (Scopus)

Original language	English
Pages (from-to)	639-643
Number of pages	5
Journal	Pathology
Volume	49
Issue number	6
Early online date	18 Aug 2017
DOIs	https://doi.org/10.1016/j.pathol.2017.04.011
Publication status	Published - Oct 2017

Access to Document

10.1016/j.pathol.2017.04.011

Cite this

@article{052e036573e2485ab6ab55c002aecadb,

title = "Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy?: Implications for pathology testing",

keywords = "Administration, Oral, Anticoagulants/administration & dosage, Dabigatran/administration & dosage, Humans, Prescriptions/statistics & numerical data, Pyrazoles/administration & dosage, Pyridones/administration & dosage, Rivaroxaban/administration & dosage, Thromboembolism/drug therapy, Warfarin/administration & dosage",

author = "Favaloro, {Emmanuel J} and Leonardo Pasalic and Giuseppe Lippi",

year = "2017",

month = oct,

doi = "10.1016/j.pathol.2017.04.011",

language = "English",

volume = "49",

pages = "639--643",

journal = "Pathology",

issn = "1465-3931",

publisher = "Lippincott Williams & Wilkins",

number = "6",

}

TY - JOUR

T1 - Replacing warfarin therapy with the newer direct oral anticoagulants, or simply a growth in anticoagulation therapy?

T2 - Implications for pathology testing

AU - Favaloro, Emmanuel J

AU - Pasalic, Leonardo

AU - Lippi, Giuseppe

PY - 2017/10

Y1 - 2017/10

KW - Administration, Oral

KW - Anticoagulants/administration & dosage

KW - Dabigatran/administration & dosage

KW - Humans

KW - Prescriptions/statistics & numerical data

KW - Pyrazoles/administration & dosage

KW - Pyridones/administration & dosage

KW - Rivaroxaban/administration & dosage

KW - Thromboembolism/drug therapy

KW - Warfarin/administration & dosage

U2 - 10.1016/j.pathol.2017.04.011

DO - 10.1016/j.pathol.2017.04.011

M3 - Letter

C2 - 28826832

SN - 1465-3931

VL - 49

SP - 639

EP - 643

JO - Pathology

JF - Pathology

IS - 6

ER -